博文
靶向抗耐药性乳腺癌PROTACs降解剂药物研究
||
靶向抗耐药性乳腺癌PROTACs降解剂药物研究https://www.ebiotrade.com/newsf/2023-5/20230513072331831.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=95404e75-9273-44b1-95de-aa141d251193
| 01. | Humans | 108 篇 | 61.364% |
| 02. | Female | 70 篇 | 39.773% |
| 03. | Breast Neoplasms | 62 篇 | 35.227% |
| 04. | Cell Line, Tumor | 53 篇 | 30.114% |
| 05. | Drug Resistance, Neoplasm | 33 篇 | 18.750% |
| 06. | Cell Proliferation | 24 篇 | 13.636% |
| 07. | Animals | 21 篇 | 11.932% |
| 08. | Antineoplastic Agents | 20 篇 | 11.364% |
| 09. | Triple Negative Breast Neoplasms | 19 篇 | 10.795% |
| 10. | Apoptosis | 16 篇 | 9.091% |
https://m.sciencenet.cn/blog-280034-1387850.html
上一篇：帕金森病患者与健康患者说话方式不同
下一篇：阿尔茨海默病的遗传表型: 机制和潜在的疗法 文献信息分析
